Product type number as specified by the Swiss Structured Products Association (SSPA): 1300
Please consult the termsheet and the accompanying issue prospectus for information on the exact product functionality, product details and risks.
Scenario 1 | Scenario 2 | Scenario 3 | |
---|---|---|---|
Description | Rising underlying | Stagnating underlying | Falling underlying |
Underlying value | 20% share A 20% share B 20% share C 20% D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
20% share A 20% share B 20% share C 20% share D 20% share E |
Term | 5 years | 5 years | 5 years |
Issue price | CHF 100 | CHF 100 | CHF 100 |
Capital employed | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) | CHF 10'000 (100 Zertifikate) |
Basket at initial fixing | CHF 100 | CHF 100 | CHF 100 |
Basket at maturity | CHF 120 | CHF 100 | CHF 80 |
Performance basket | 20% | 0% | -20% |
Scenario 1 | Scenario 2 | Scenario 3 | |
---|---|---|---|
Calculation | 100 Zertifikate * 120 | 100 Zertifikate * 100 | 100 Zertifikate * 80 |
Redemption | CHF 12'000 | CHF 10'000 | CHF 8'000 |
Profit / Loss | 20% | 0% | -20% |
19.313% p.a. ZKB Barrier Reverse Convertible, 10.01.2025 on worst of LOGN SE/AMS SE 135804789 / CH1358047897 |
ZKB Autocallable Barrier Reverse Convertible on worst of The Swatch Group AG/Alcon AG/Sandoz Group A... 132910962 / CH1329109628 |
ZKB Barrier Reverse Convertible mit bedingtem Coupon on worst of Salesforce.com Inc/NVIDIA Corp/Supe... 132913957 / CH1329139575 |
ZKB Autocallable Barrier Reverse Convertible auf Halliburton Co 127347332 / CH1273473327 |
ZKB Barrier Reverse Convertible on worst of Sanofi SA/Novartis AG/Bayer AG 130398728 / CH1303987288 |